Diabetes and Breast Cancer: An Analysis of Signaling Pathways

Cancer and diabetes are two of the most prevalent and complicated diseases. Several epidemiological studies have found a link between type 2 diabetes and an increased risk of breast cancer. This chapter aims to highlight the advances in understanding the mechanisms that connect diabetes and breast cancer. Alterations in glucose metabolism, hyperinsulinemia, insulin resistance, changes in the hormonal environment, and substrate availability create a metabolic environment that is particularly favourable for the growth of tumours. Therefore, it is vital to understand the correlation between diabetes mellitus and breast cancer. A precise analysis of these relationships could help in finding biomarkers that can predict disease risk and prognosis, and aid in selecting appropriate, evidence-based diagnostic and therapeutic approaches

The understanding of the complex relationship between the immune and nervous systems has significantly evolved in recent years. It is now recognized that the inflammatory response and interactions between these two systems play crucial roles in the development and progression of neurodegenerative diseases and injuries. The immune and nervous systems are intricately connected, with bidirectional communication pathways that allow them to influence each other's functions. This cross-talk is mediated by various signaling molecules including cytokines, chemokines, and neurotransmitters. Neuropathic pain is a debilitating condition that arises as a result of damage or dysfunction in the central nervous system (CNS) or peripheral nervous system (PNS). Neuropathic pain is a common pathological symptom of cancer and diabetes. Neuropathic pain can be generated by resulting injury to peripheral or central neurons through various neural pathways, ion channels, receptors, and neurotransmitters. In this article, we elaborate on the recent progress in the understanding of mechanism of the neuroinflammation. First, we provide current knowledge of neuroinflammatory molecules and their association with neuroinflammation. Subsequently, we describe recent advances in the understanding of the pathophysiology of neuropathic pain in PNS and CNS, emphasizing breast cancer and diabetes. Finally, we highlighted the current challenges of molecular understanding and diagnosis regarding targeted therapies for the treatment of neuropathic pain. 

Uncontrolled cell division resulting in cancer is a significant contributor to mortality rates, with breast cancer being the most common form affecting women. When the disease progresses, the uncontrolled cell division can spread through the bloodstream to other parts of the body, making treatment through chemotherapy and radiation therapy challenging. As such, there is an urgent need for the discovery of new drugs and targets to combat this disease. This chapter delves into the physiological role of insulin and hypoxia in breast cancer cell invasion and metastasis, which can potentially increase the druggability of the pathway. It is a valuable resource for those researching new druggable targets in these pathways.

Recent progress in genetics research has accelerated our comprehension of complex disorders such as type 2 Diabetes Mellitus and breast cancer. Genome-wide association studies on a large scale have facilitated our exploration of the underlying pathology. Individuals with type 2 diabetes are at a higher risk of developing several types of cancer as a result of common risk factors, such as obesity, poor diet, aging, and low levels of physical activity. While several susceptibility genes have been identified, we must consider tissue specificity and direction of effect when investigating the shared genetic aetiology. Techniques such as Mendelian randomisation allow us to unravel the link between the two diseases and answer critical questions. By deconstructing the type 2 Diabetes GRS and studying genetic variants in relation to their biological function, we may be able to evaluate the causal association between different groups and various cancer types. Genetic research also has the potential to investigate epigenetic modifications that contribute to the development of cancer. This work explores the association between the genetic similarity between type 2 diabetes and breast cancer.

Diabetes and obesity are linked to a higher risk of breast and other cancers. In addition to the direct effects of hyperglycaemia and insulin resistance on breast cancer cells, the complications of diabetes, obesity, and metabolic syndrome are characterised by a dysfunctional endothelium and increased inflammation in tissue phenomena that are intimately related and occur concurrently in breast cancer progression. However, the complexity of the underlying mechanisms, together with the interplay of diet and physical activity contributing to energy balance and the role of adipose tissue, hyperglycaemia, insulin resistance, and glucose intolerance, pose challenges to our understanding of the basis of this increased risk. In addition to being an established risk factor for postmenopausal breast cancer, abdominal obesity, also known as central obesity, may also raise the chance of triple-negative breast cancer, which is more common in premenopausal women. This chapter explains how various parameters like oestrogen, mammography, density, adipokines, insulin-signalling pathway activation, and inflammatory conditions, may play a part in this seemingly contradictory association. A key focus of this chapter is to better understand the impact of obesity and diabetes in the pathogenesis of breast cancer and, hence, provide some clarity into the interrelationships involved in between.

Breast cancer has continued to be one of the most common causes of cancer death among females without sparing either those in modern societies or rural communities. Breast cancer is, in general, the uncontrolled cell growth in the mammary glands. This encompasses stromal and epithelial cells as the major cause of breast cancer. The disruption of communication between stromal and epithelial cells is one of the inducers of breast cancer. The mechanism surrounding this uncontrolled cell growth is postulated to be due to the role played by cadherin molecules and WNT signaling in mammary gland tumorogenesis and the hyperglycemia-driven modulation of the progression of breast cancer. Among different FAT cadherin molecules, repression of FAT4 mediates the Wnt signaling cascades, which regulate tissue homeostasis, vascularization, tumorigeneses, cell invasion, and metastasis. The epithelial-to-mesenchymal transition (EMT), which is promoted by transforming growth factor beta (TGF-beta) through the Wnt Signaling pathway, leads to the progression of breast cancer. This fundamental discussion may contribute to designing new signaling-targeted therapeutic approaches to mitigate breast cancer and associated factors for hyperglycemia. 

Breast cancer (BC) and Diabetes Mellitus (DM) are medical conditions that are becoming more common in many developed nations. When compared with healthy individuals, diabetic people have an elevated risk of BC and more fatalities from the disease. This implies an association and that the two conditions share risk factors and pathophysiological pathways. Although the causal processes beneath this connection remain incompletely understood, plausible ties include hyperinsulinemia, insulin resistance, oxidative stress, chronic inflammation, hyperglycaemia, and hormonal. Each of these conditions has been proposed for fostering tumour progression in numerous manners. Although hyperglycaemia is one of the most extensively researched metabolic abnormalities in DM, the consequences of high blood sugar on malignancy have garnered less scrutiny than the influence of insulin, insulin-like growth factor-1 (IGF-1), oxidative stress, and chronic inflammation on the progression of cancer. The purpose of this chapter is to provide insight into the link between impaired glycaemic status and oxidative stress of DM with the causation, type, progression, and mortality of BC. Several unexplored areas exist, and new hypotheses may emerge in the days to come.

Breast cancer (BC) is a multifactorial disease with a poor prognosis. Tumour-associated macrophages (TAMs), also known as TAMs, play a significant role in promoting tumour growth, facilitating angiogenesis, participating in tissue remodelling processes, and suppressing the adaptive immune response within breast tumours. TAMs usually located within the microenvironment of solid tumours or infiltrating the tumour's tissues, and their presence in BC is linked to an unfavourable clinical prognosis. The IGF signalling system, comprising IGF1, IGFBPs, and IGFR1, plays a key role in cancer development and progression, and its association with TAM in breast cancer has been extensively investigated. In this review, we delve into the interaction between TAM and IGF1 signalling in BC. We also proposed the concept of M2 polarization - as a possible alternative to cancer chemotherapy. 

Both diabetes and breast cancer are well-established diseases with similar underlying causes that can be influenced by various risk factors. Research suggests that insulin can play a significant role in the spread of breast cancer cells. Moreover, certain medicinal plants have antidiabetic and anticancer properties, making them promising candidates for dual-acting therapies. This article provides a review of the current scientific literature on these plants, including a tabular summary of the findings. By exploring the potential of these medicinal plants further, there is a possibility of developing effective natural therapies to control the invasion and migration of breast cancer cells in diabetic patients.